Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac sarcoidosis.

Uma S Ayyala1, Ajith P Nair, Maria L Padilla

  • 1Division of Pulmonary and Critical Care Medicine, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029, USA.

Clinics in Chest Medicine
|June 10, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nintedanib in Post-COVID Interstitial Lung Disease: a double-blind, randomized, placebo-controlled Clinical Trial.

Annals of the American Thoracic Society·2026
Same author

Management of Dialysis for Patients Receiving Mechanical Circulatory Support.

Journal of the American Society of Nephrology : JASN·2026
Same author

Kidney Function Trajectories With Mechanical Circulatory Support.

Kidney international reports·2025
Same author

AAIM recommendations for post-core clerkship clinical rotations to prepare for residency in internal medicine.

The American journal of medicine·2025
Same author

Construct and Predictive Validity of the Kansas City Cardiomyopathy Questionnaire in Adult Congenital Heart Disease.

JACC. Advances·2025
Same author

Therapeutic left-to-right shunting in heart failure.

European heart journal·2025
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Sarcoidosis is usually benign, but cardiac involvement worsens the prognosis. Identifying patients at risk for sudden cardiac death is crucial for appropriate management of cardiac sarcoidosis.

Area of Science:

  • Cardiology
  • Immunology
  • Systemic Diseases

Background:

  • Sarcoidosis is a systemic inflammatory disease.
  • Cardiac involvement significantly alters sarcoidosis prognosis.
  • Common cardiac manifestations include arrhythmias and heart failure.

Purpose of the Study:

  • To highlight the impact of cardiac sarcoidosis on prognosis.
  • To outline clinical manifestations and treatment strategies.
  • To emphasize the importance of risk stratification for sudden cardiac death.

Main Methods:

  • Review of clinical manifestations of cardiac sarcoidosis.
  • Discussion of treatment modalities including immunosuppression and device implantation.
  • Emphasis on risk stratification protocols.

Related Experiment Videos

Main Results:

  • Cardiac sarcoidosis presents with arrhythmias, conduction abnormalities, and heart failure.
  • Treatment involves immunosuppressants, pacemakers, and defibrillators.
  • Risk stratification is vital for asymptomatic patients.

Conclusions:

  • Cardiac sarcoidosis necessitates specific management strategies.
  • Early risk stratification can prevent sudden cardiac death.
  • Multidisciplinary approach is key for managing cardiac sarcoidosis.